FundCanna Changes Cannabis Underwriting as Rescheduling Uncertainty Persists

FundCanna CEO Adam Stettner told The Dales Report that his firm has begun separating medical and adult-use licenses in underwriting as rescheduling uncertainty changes risk analysis. Oklahoma operators seeking capital should expect lenders to scrutinize license type, 280E exposure and regulatory structure even before DEA reaches a final broader scheduling decision.